跳至主要内容
临床试验/DRKS00004969
DRKS00004969已完成不适用

Efficacy of Actikerall® in patients with actinic keratosis (clinical grade I or II according to Olsen) in relation to treatment duration

Almirall Hermal GmbH0 个研究点目标入组 1,051 人开始时间: 2013年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,051

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Enrolled patients are to be immune-competent, adult patients suffering from actinic keratosis (clinical stage I or II according to Olsen), who are to be treated with Actikerall® based upon physicians´ therapeutic decision.

排除标准

  • *hypersensitivity to fluorouracil or salicylic acid
  • *planned or existing pregnancy or nursing period
  • *renal insufficiency
  • *(pre-)medication containing brivudine, sorivudine or analogs, that has been terminated less than four weeks prior to therapy start with Actikerall®
  • *immune suppression

研究者

相似试验

Efficacy of Actikerall® in patients with actinic... | 临床试验